USD 1.01
(-10.67%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 446.95 Million USD | -27.45% |
2022 | 472.31 Million USD | 14.48% |
2021 | 412.59 Million USD | 42.33% |
2020 | 289.88 Million USD | 166.45% |
2019 | 108.79 Million USD | 8.4% |
2018 | 100.36 Million USD | -25.57% |
2017 | 134.83 Million USD | 6.9% |
2016 | 126.13 Million USD | -16.51% |
2015 | 151.08 Million USD | 6.11% |
2014 | 142.37 Million USD | 38.73% |
2013 | 102.63 Million USD | 7.9% |
2012 | 95.11 Million USD | -4.08% |
2011 | 99.15 Million USD | -14.83% |
2010 | 116.41 Million USD | 5.27% |
2009 | 110.58 Million USD | 35.28% |
2008 | 81.74 Million USD | 32.76% |
2007 | 61.57 Million USD | 45.43% |
2006 | 42.34 Million USD | 15.15% |
2005 | 36.76 Million USD | 46.96% |
2004 | 25.01 Million USD | 79.96% |
2003 | 13.9 Million USD | 435.88% |
2002 | 2.59 Million USD | -99.9% |
2001 | 2.5 Billion USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 73.78 Million USD | -18.7% |
2024 Q2 | 82.44 Million USD | 11.74% |
2023 Q3 | 107.71 Million USD | -1.95% |
2023 Q4 | 90.75 Million USD | -15.74% |
2023 FY | 342.68 Million USD | -27.45% |
2023 Q1 | 112.04 Million USD | -6.6% |
2023 Q2 | 109.85 Million USD | -1.95% |
2022 Q3 | 113.21 Million USD | -8.68% |
2022 Q4 | 119.95 Million USD | 5.95% |
2022 FY | 472.31 Million USD | 14.48% |
2022 Q2 | 123.98 Million USD | 7.66% |
2022 Q1 | 115.16 Million USD | -11.85% |
2021 Q3 | 93.78 Million USD | -1.15% |
2021 Q1 | 93.27 Million USD | 11.01% |
2021 FY | 412.59 Million USD | 42.33% |
2021 Q2 | 94.88 Million USD | 1.72% |
2021 Q4 | 130.64 Million USD | 39.3% |
2020 FY | 289.88 Million USD | 166.45% |
2020 Q1 | 34.63 Million USD | 31.19% |
2020 Q2 | 86.15 Million USD | 148.77% |
2020 Q3 | 85.07 Million USD | -1.25% |
2020 Q4 | 84.02 Million USD | -1.24% |
2019 Q3 | 37.11 Million USD | 106.61% |
2019 FY | 108.79 Million USD | 8.4% |
2019 Q1 | 27.31 Million USD | -13.78% |
2019 Q2 | 17.96 Million USD | -34.24% |
2019 Q4 | 26.39 Million USD | -28.88% |
2018 Q2 | 26.72 Million USD | -23.23% |
2018 Q4 | 31.68 Million USD | 6.64% |
2018 FY | 100.36 Million USD | -25.57% |
2018 Q1 | 34.81 Million USD | -17.75% |
2018 Q3 | 29.71 Million USD | 11.18% |
2017 Q2 | 30.94 Million USD | 2.87% |
2017 FY | 134.83 Million USD | 6.9% |
2017 Q4 | 42.32 Million USD | 34.42% |
2017 Q3 | 31.48 Million USD | 1.74% |
2017 Q1 | 30.08 Million USD | 4.75% |
2016 FY | 126.13 Million USD | -16.51% |
2016 Q4 | 28.72 Million USD | -14.99% |
2016 Q3 | 33.78 Million USD | -25.89% |
2016 Q2 | 45.58 Million USD | -1.26% |
2016 Q1 | 46.16 Million USD | 389.21% |
2015 Q3 | 41.57 Million USD | -28.56% |
2015 Q2 | 58.19 Million USD | -6.03% |
2015 Q1 | 61.92 Million USD | 43.31% |
2015 FY | 151.08 Million USD | 6.11% |
2015 Q4 | 9.43 Million USD | -77.3% |
2014 Q1 | 29.42 Million USD | 32.84% |
2014 Q2 | 34.76 Million USD | 18.16% |
2014 Q3 | 34.97 Million USD | 0.58% |
2014 Q4 | 43.21 Million USD | 23.57% |
2014 FY | 142.37 Million USD | 38.73% |
2013 Q3 | 22.78 Million USD | -19.81% |
2013 Q2 | 28.41 Million USD | -2.99% |
2013 FY | 102.63 Million USD | 7.9% |
2013 Q4 | 22.15 Million USD | -2.77% |
2013 Q1 | 29.28 Million USD | 9.24% |
2012 Q3 | 23.57 Million USD | 8.29% |
2012 Q4 | 26.8 Million USD | 13.72% |
2012 FY | 95.11 Million USD | -4.08% |
2012 Q1 | 22.95 Million USD | 1.75% |
2012 Q2 | 21.77 Million USD | -5.17% |
2011 Q3 | 22.03 Million USD | -14.2% |
2011 Q1 | 28.88 Million USD | 10.37% |
2011 Q2 | 25.67 Million USD | -11.1% |
2011 Q4 | 22.56 Million USD | 2.42% |
2011 FY | 99.15 Million USD | -14.83% |
2010 Q4 | 26.16 Million USD | 6.7% |
2010 Q2 | 31.89 Million USD | -5.72% |
2010 Q3 | 24.52 Million USD | -23.1% |
2010 Q1 | 33.82 Million USD | 17.14% |
2010 FY | 116.41 Million USD | 5.27% |
2009 FY | 110.58 Million USD | 35.28% |
2009 Q1 | 30.01 Million USD | 86.28% |
2009 Q4 | 28.87 Million USD | 17.56% |
2009 Q3 | 24.56 Million USD | -9.44% |
2009 Q2 | 27.12 Million USD | -9.63% |
2008 FY | 81.74 Million USD | 32.76% |
2008 Q4 | 16.11 Million USD | -1.18% |
2008 Q3 | 16.3 Million USD | -30.3% |
2008 Q2 | 23.39 Million USD | -9.79% |
2008 Q1 | 25.93 Million USD | 31.1% |
2007 Q1 | 13.65 Million USD | 61.31% |
2007 Q2 | 14.71 Million USD | 7.8% |
2007 FY | 61.57 Million USD | 45.43% |
2007 Q3 | 13.42 Million USD | -8.8% |
2007 Q4 | 19.78 Million USD | 47.37% |
2006 Q2 | 12.23 Million USD | 11.28% |
2006 Q1 | 10.99 Million USD | 3.17% |
2006 Q4 | 8.46 Million USD | -20.51% |
2006 FY | 42.34 Million USD | 15.15% |
2006 Q3 | 10.64 Million USD | -12.98% |
2005 Q1 | 7.85 Million USD | 10.56% |
2005 Q2 | 38.67 Million USD | 392.13% |
2005 Q3 | 9.58 Million USD | -75.22% |
2005 Q4 | 10.65 Million USD | 11.21% |
2005 FY | 36.76 Million USD | 46.96% |
2004 Q2 | 5.58 Million USD | 18.77% |
2004 FY | 25.01 Million USD | 79.96% |
2004 Q1 | 4.7 Million USD | 17.92% |
2004 Q4 | 7.1 Million USD | -6.73% |
2004 Q3 | 7.61 Million USD | 36.37% |
2003 Q4 | 3.98 Million USD | 15.97% |
2003 FY | 13.9 Million USD | 435.88% |
2003 Q3 | 3.44 Million USD | -2.46% |
2003 Q2 | 3.52 Million USD | -62.93% |
2003 Q1 | 9.51 Million USD | 0.0% |
2002 FY | 2.59 Million USD | -99.9% |
2001 Q3 | 493.05 Million USD | 3.92% |
2001 Q4 | 575.77 Million USD | 16.78% |
2001 FY | 2.5 Billion USD | 0.0% |
2001 Q2 | 474.44 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 682.6 Million USD | 34.523% |
Addus HomeCare Corporation | 339.87 Million USD | -31.504% |
AirSculpt Technologies, Inc. | 121.9 Million USD | -266.64% |
Amedisys, Inc. | 457.07 Million USD | 2.215% |
American Oncology Network, Inc. | 66.05 Million USD | -576.616% |
Astrana Health, Inc. | 214.95 Million USD | -107.925% |
Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 24.937% |
IMAC Holdings, Inc. | 3.84 Million USD | -11513.312% |
biote Corp. | 127.48 Million USD | -250.597% |
Cryo-Cell International, Inc. | 22.9 Million USD | -1851.637% |
Cross Country Healthcare, Inc. | 432.06 Million USD | -3.446% |
COMPASS Pathways plc | -242.93 Thousand USD | 184077.805% |
DocGo Inc. | 178.95 Million USD | -149.763% |
The Ensign Group, Inc. | 590.75 Million USD | 24.343% |
Healthcare Services Group, Inc. | 251.45 Million USD | -77.75% |
InnovAge Holding Corp. | 132.06 Million USD | -238.436% |
Assure Holdings Corp. | -2.19 Million USD | 20471.559% |
The Joint Corp. | 107.14 Million USD | -317.128% |
LifeStance Health Group, Inc. | 302.09 Million USD | -47.95% |
Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 41807.095% |
NewGenIvf Group Limited | 1.68 Million USD | -26476.049% |
Novo Integrated Sciences, Inc. | 4.95 Million USD | -8924.384% |
Option Care Health, Inc. | 981.22 Million USD | 54.449% |
P3 Health Partners Inc. | 31.63 Million USD | -1312.84% |
P3 Health Partners Inc. | 31.63 Million USD | -1312.84% |
The Pennant Group, Inc. | 61.9 Million USD | -621.985% |
Surgery Partners, Inc. | 529.4 Million USD | 15.574% |
Syra Health Corp. Class A Common Stock | 1.41 Million USD | -31556.066% |
Talkspace, Inc. | 74.38 Million USD | -500.903% |
Talkspace, Inc. | 74.38 Million USD | -500.903% |
The Oncology Institute, Inc. | 59.57 Million USD | -650.259% |
The Oncology Institute, Inc. | 59.57 Million USD | -650.259% |